Diabetes is one of the major life threatening diseases worldwide. It creates major health problems in urban India. Glycogen
Synthase Kinase-3 (GSK-3) protein of human is known for phosphorylating and inactivating glycogen synthase which also acts as a
negative regulator in the hormonal control of glucose homeostasis. In traditional medicine, Momordica charantia is used as antidiabetic
plant because of its hypoglycemic effect. Hence to block the active site of the GSK-3 protein three anti-diabetic compounds
namely, charantin, momordenol & momordicilin were taken from Momordica charantia for docking study and calculation of binding
energy. The aim of present investigation is to find the binding energy of three major insulin-like active compounds against
glycogen synthase kinase-3 (GSK-3), one of the key proteins involved in carbohydrate metabolism, with the help of molecular
docking using ExomeTM Horizon suite. The study recorded minimum binding energy by momordicilin in comparison to the others.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.